HUP0203153A2 - Kombinációs kemoterápia - Google Patents

Kombinációs kemoterápia

Info

Publication number
HUP0203153A2
HUP0203153A2 HU0203153A HUP0203153A HUP0203153A2 HU P0203153 A2 HUP0203153 A2 HU P0203153A2 HU 0203153 A HU0203153 A HU 0203153A HU P0203153 A HUP0203153 A HU P0203153A HU P0203153 A2 HUP0203153 A2 HU P0203153A2
Authority
HU
Hungary
Prior art keywords
combination chemotherapy
combination
chemotherapy
acetyldinaline
carboplatin
Prior art date
Application number
HU0203153A
Other languages
English (en)
Inventor
Wayne Daniel Klohs
Ronald Lynn Merriman
Original Assignee
Warner-Lambert Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Co. filed Critical Warner-Lambert Co.
Publication of HUP0203153A2 publication Critical patent/HUP0203153A2/hu
Publication of HUP0203153A3 publication Critical patent/HUP0203153A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Az acetildinaline paclitaxellel és/vagy carboplatinnal kombinálvaszinergikus hatású a rák kezelésében. Ó
HU0203153A 1999-11-10 2000-11-03 Combination chemotherapy HUP0203153A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16488999P 1999-11-10 1999-11-10
US22256100P 2000-08-03 2000-08-03
PCT/US2000/030377 WO2001034131A2 (en) 1999-11-10 2000-11-03 Combination chemotherapy

Publications (2)

Publication Number Publication Date
HUP0203153A2 true HUP0203153A2 (hu) 2003-01-28
HUP0203153A3 HUP0203153A3 (en) 2005-01-28

Family

ID=26860956

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203153A HUP0203153A3 (en) 1999-11-10 2000-11-03 Combination chemotherapy

Country Status (17)

Country Link
EP (1) EP1229916A2 (hu)
JP (1) JP2003513912A (hu)
KR (1) KR20020060226A (hu)
CN (1) CN1387438A (hu)
AR (1) AR026400A1 (hu)
AU (1) AU1583201A (hu)
CA (1) CA2386876A1 (hu)
GT (1) GT200000194A (hu)
HU (1) HUP0203153A3 (hu)
IL (1) IL149363A0 (hu)
NZ (1) NZ518668A (hu)
PA (1) PA8506201A1 (hu)
PE (1) PE20011028A1 (hu)
PL (1) PL355170A1 (hu)
SV (1) SV2001000212A (hu)
UY (1) UY26431A1 (hu)
WO (1) WO2001034131A2 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
PE20050206A1 (es) * 2003-05-26 2005-03-26 Schering Ag Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
JP5107579B2 (ja) 2003-12-02 2012-12-26 ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション 新規の種類のヒストン脱アセチル化酵素阻害剤としてのＺｎ２＋キレートモチーフ係留短鎖脂肪酸
US7951780B2 (en) 2004-02-25 2011-05-31 Astellas Pharma Inc. Antitumor agent
CN101014365B (zh) * 2004-07-16 2011-04-13 辉瑞产品公司 使用抗-igf-1r抗体联合治疗非血液的恶性肿瘤
PL2415382T3 (pl) 2010-08-06 2013-02-28 Electrolux Home Products Corp Nv Zmywarka nablatowa
EP3461488A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dbait molecule and a hdac inhibitor for treating cancer
EP3461480A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
WO2023041805A1 (en) 2021-09-20 2023-03-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
WO2023194441A1 (en) 2022-04-05 2023-10-12 Istituto Nazionale Tumori Irccs - Fondazione G. Pascale Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases

Also Published As

Publication number Publication date
UY26431A1 (es) 2000-12-29
GT200000194A (es) 2002-05-03
PE20011028A1 (es) 2001-10-12
CN1387438A (zh) 2002-12-25
WO2001034131A2 (en) 2001-05-17
AU1583201A (en) 2001-06-06
AR026400A1 (es) 2003-02-12
SV2001000212A (es) 2001-10-25
PL355170A1 (en) 2004-04-05
CA2386876A1 (en) 2001-05-17
IL149363A0 (en) 2002-11-10
JP2003513912A (ja) 2003-04-15
NZ518668A (en) 2004-04-30
PA8506201A1 (es) 2002-12-11
KR20020060226A (ko) 2002-07-16
WO2001034131A3 (en) 2002-05-10
HUP0203153A3 (en) 2005-01-28
EP1229916A2 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
CA105195S (en) Bottle
AU2003237367A8 (en) Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
WO2004103301A3 (en) Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
SG150559A1 (en) Antineoplastic combinations of cci-779 and rituximab
CA115590S (en) Back therapy device
HK1022301A1 (en) Conjugates of cisdocosahexaenoic acid and paclitaxel
FR2869231B1 (fr) Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
NO20054988D0 (no) Preparater og metoder for behandling av cancer
AU302959S (en) Toothbrush
IL182983A0 (en) 4-hydroxybenzomorphans
HRPK20041072B3 (en) Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
HUP0203153A2 (hu) Kombinációs kemoterápia
SE9904377D0 (sv) Pharmaceutical combinations
TR200402628T4 (tr) Androjenetik ve yaygın alopezinin tedavisinde melatonin maddesinin kullanımı
ATE344670T1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
EP1503748A4 (en) DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY
DK1558620T3 (da) Rutheniumkomplekser med anticancervirkning
TR200302193T4 (tr) Kombinasyon kemoterapisi.
TR199802703T2 (xx) HIV tedavisinde Vx478, Zidov�din, ve/veya 1592U89 i�eren kombinasyonlar�n kullan�m�.
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
ECSP003755A (es) Quimioterapia de combinacion
MXPA05002477A (es) Asialo-interferones y el tratamiento de cancer de higado.
AU300372S (en) Personal care product
DOP2000000092A (es) Quimioterapia de combinación
AU300157S (en) Underwear